Icon

FLONASE (nda020121)- (0.05MG/SPRAY)

FLUTICASONE PROPIONATE HALEON US HOLDINGS
0.05MG/SPRAY
No No
2004-May-14 Expired
None None
None No
FLONASE nasal spray is a corticosteroid indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adult and pediatric patients aged 4 years and older.
4 0 4
Total Other Developers 14
Drugs with Suitability No
0.05MG/SPRAY ** ** - 3 -
NDA Sales Available Total Generic Sales Available
No 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****-**** ******** ***. *********** **** ****** ****, ********, **** (**) *****, ****** ****** (***) ***
****** ***** ***** *************** *** *** *********** ***** *************** ****** *** ** ****** ******, ******** **. (**) ******* **** ** **** ********** **** *.*.*** ****** ***** ***** ****** (***), *****, ***** *****, ****** (***) ***
****** ****** *** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** ***** ***** ********* ******* *** (*** *****) *********** *** ******* ******, **********, *** **** (**) *****, ****** ****** (***) ***
****** ********* ** ****** ***** ***************, ***. *********** **** **** ******, ****** *****, ******** (**) *****, ****** ****** (***) ***
****** ********* ** ********* *.*.*. *** *********** *** ***** *, ******** *******, ***** *****, ***** (***) ***
****** ********* ** ***** ********** ******* *** *********** **** - **, **** **: * - **, **/*, **/*, *.*.*.*. *******, ****** & ********: *******, *******, *********** ******, ***** (***) ***
****** ********* ** ********* *************** **********, ***. *********** *** ******* ******, **********, *** **** (**) *****, ****** ****** (***) ***
****** ********* ** ****** ****** *****, ***. *********** **** **** ****, ****** *****, ******** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.